| Literature DB >> 35987656 |
Nurnabi Sheikh1, Abdur Razzaque Sarker2, Marufa Sultana3, Rashidul Alam Mahumud4, Sayem Ahmed5, Mohammad Touhidul Islam6, Susan Howick7, Alec Morton7.
Abstract
BACKGROUND: Financial risk protection and equity are two fundamental components of the global commitment to achieve Universal Health Coverage (UHC), which mandates health system reform based on population needs, disease incidence, and economic burden to ensure that everyone has access to health services without any financial hardship. We estimated disease-specific incidences of catastrophic out-of-pocket health expenditure and distress financing to investigate progress toward UHC financial risk indicators and investigated inequalities in financial risk protection indicators by wealth quintiles. In addition, we explored the determinants of financial hardship indicators as a result of hospitalization costs.Entities:
Keywords: Bangladesh; Catastrophic health expenditure; Distress financing; Inequalities; Out-of-pocket payment; Universal Health Coverage
Mesh:
Year: 2022 PMID: 35987656 PMCID: PMC9392951 DOI: 10.1186/s12939-022-01712-6
Source DB: PubMed Journal: Int J Equity Health ISSN: 1475-9276
Background and household characteristics of the study participants
| Variables | n | % |
|---|---|---|
| | 91,414 | 49.8 |
| | 92,343 | 50.3 |
| | 58,298 | 31.7 |
| | 115,883 | 63.1 |
| | 9,576 | 5.2 |
| 45,423 | ||
| 183,757 | ||
| 3,220 | ||
| | ||
| | 310 | 0.7 |
| | 15,383 | 33.9 |
| | 29,730 | 65.5 |
| | ||
| | 27,820 | 61.3 |
| | 14,201 | 31.3 |
| | 3,402 | 7.5 |
| | ||
| | 37,192 | 81.9 |
| | 6,925 | 15.3 |
| | 1,306 | 2.9 |
| | ||
| | 34,098 | 75.1 |
| | 8,802 | 19.4 |
| | 2,523 | 5.6 |
| | ||
| | 23,423 | 51.6 |
| | 13,357 | 29.4 |
| | 6,676 | 14.7 |
| | 1,967 | 4.3 |
| | ||
| | 42,410 | 93.4 |
| | 2,837 | 6.3 |
| | 176 | 0.4 |
| | ||
| | 6,288 | 13.8 |
| | 23,877 | 52.6 |
| | 15,258 | 33.6 |
| 4.1 ± 1.6 | ||
| | ||
| | 4,234 | 9.3 |
| | 7,801 | 17.2 |
| | 9,223 | 20.3 |
| | 7,135 | 15.7 |
| | 2,849 | 6.3 |
| | 5,642 | 12.4 |
| | 5,685 | 12.5 |
| | 2,854 | 6.3 |
| | ||
| | 31,621 | 69.6 |
| | 13,802 | 30.4 |
| | ||
| | 9,332 | 20.5 |
| | 8,824 | 19.4 |
| | 9,069 | 20.0 |
| | 9,203 | 20.3 |
| | 8,995 | 19.8 |
Health care provider specific-hospitalization (12 months prior to the survey) and average length of hospital stay by diseases in Bangladesh
| Diseases/reasons for hospitalization | Hospitalization in last 12 months | Length of hospital stay (in days) (Mean ± SD) | ||||
|---|---|---|---|---|---|---|
| Diarrhea/Dysentery | 288 (82.1) | 63 (17.9) | 351 (10.9) | 4.0 ± 4.7 | 2.9 ± 1.7 | 3.8 ± 4.3 |
| Fever | 142 (75.5) | 46 (24.5) | 188 (5.8) | 4.8 ± 3.9 | 5.3 ± 3.4 | 4.9 ± 3.8 |
| Pain | 171 (63.6) | 98 (36.4) | 269 (8.4) | 9.0 ± 25.2 | 5.7 ± 10.3 | 7.8 ± 21.0 |
| Injury/Accident | 260 (70.5) | 109 (29.5) | 369 (11.5) | 9.1 ± 11.6 | 12.3 ± 20.3 | 10.1 ± 14.7 |
| Blood pressure | 78 (70.9) | 32 (29.1) | 110 (3.4) | 5.7 ± 7.5 | 4.5 ± 2.8 | 5.4 ± 6.5 |
| Heart disease | 145 (63.9) | 82 (36.1) | 227 (7.1) | 8.0 ± 15.6 | 9.0 ± 7.9 | 8.4 ± 13.3 |
| Respiratory Diseases/ Asthma/Bronchitis | 146 (69.2) | 65 (30.8) | 211 (6.6) | 6.9 ± 7.2 | 6.1 ± 5.5 | 6.6 ± 6.7 |
| Weakness/Dizziness | 64 (64.0) | 36 (36.0) | 100 (3.1) | 4.7 ± 5.5 | 4.4 ± 7.3 | 4.6 ± 6.2 |
| Pneumonia | 96 (73.3) | 35 (26.7) | 131 (4.1) | 5.5 ± 3.5 | 6.9 ± 5.3 | 5.8 ± 4.1 |
| Tuberculosis | 8 (57.1) | 6 (42.9) | 14 (0.4) | 20.1 ± 20.3 | 19.8 ± 39.3 | 20.0 ± 28.6 |
| Malaria | 6 (66.7) | 3 (33.3) | 9 (0.3) | 7.5 ± 7.1 | 3.7 ± 2.9 | 6.2 ± 6.1 |
| Jaundice | 18 (62.1) | 11 (37.9) | 29 (0.9) | 6.6 ± 7.0 | 5.8 ± 5.6 | 6.3 ± 6.4 |
| Female diseases | 52 (36.1) | 92 (63.9) | 144 (4.5) | 7.4 ± 9.1 | 7.2 ± 6.4 | 7.3 ± 7.4 |
| Child delivery and pregnancy-related diseases | 169 (30.0) | 395 (70.0) | 564 (17.5) | 5.5 ± 4.4 | 5.5 ± 2.7 | 5.5 ± 3.3 |
| Cancer | 25 (52.1) | 23 (47.9) | 48 (1.5) | 28.1 ± 44.1 | 23.2 ± 37.6 | 25.7 ± 40.7 |
| Mental health | 22 (78.6) | 6 (21.4) | 28 (0.9) | 12.3 ± 13.3 | 19.3 ± 17.1 | 13.8 ± 14.2 |
| Paralysis | 43 (69.4) | 19 (30.6) | 62 (1.9) | 7.6 ± 7.0 | 11.2 ± 9.4 | 8.7 ± 7.9 |
| Scabies/Skin diseases | 19 (67.9) | 9 (32.1) | 28 (0.9) | 10.2 ± 13.8 | 7.8 ± 6.4 | 9.4 ± 11.9 |
| Kidney Diseases | 54 (47.8) | 59 (52.2) | 113 (3.5) | 12.7 ± 17.7 | 9.4 ± 9.6 | 11.0 ± 14.1 |
| Liver Diseases | 35 (55.6) | 28 (44.4) | 63 (2.0) | 11.0 ± 13.1 | 8.4 ± 8.6 | 9.8 ± 11.4 |
| Ear/ ENT problems | 15 (46.9) | 17 (53.1) | 32 (1.0) | 11.7 ± 18.3 | 6.1 ± 4.7 | 8.7 ± 13.1 |
| Eye problem | 40 (30.8) | 90 (69.2) | 130 (4.0) | 5.3 ± 4.9 | 4.9 ± 6.6 | 5.0 ± 6.1 |
| Communicable | 841 (55.3) | 679 (44.7) | 1,520 (47.2) | 5.4 ± 6.0 | 5.8 ± 5.5 | 5.6 ± 5.8 |
| Non-communicable | 1,055 (62.1) | 645 (37.9) | 1,700 (52.8) | 8.8 ± 16.4 | 8.2 ± 13.6 | 8.6 ± 15.4 |
a Percentages based on column total
b Percentages based on row total
Fig. 1Mean OOP expenditure on hospitalization according to diseases/reasons for hospitalization and hospital types in Bangladesh
Health care provider specific mean out-of-pocket healthcare expenditure on hospitalization by diseases in Bangladesh
| Diseases/reasons for hospitalization | OOP expenditure (in BDT) due to hospitalization in last 12 months | ||
|---|---|---|---|
| Diarrhea/Dysentery | 3911 ± 4456 | 6501 ± 4599 | 4375 ± 4585 |
| Fever | 7384 ± 12,529 | 14,146 ± 13,511 | 9039 ± 13,068 |
| Pain | 12,522 ± 47,866 | 19,074 ± 41,124 | 14,909 ± 45,557 |
| Injury/Accident | 17,604 ± 23,268 | 31,687 ± 30,060 | 21,764 ± 26,222 |
| Blood pressure | 11,393 ± 11,658 | 17,295 ± 17,157 | 13,110 ± 13,674 |
| Heart disease | 15,037 ± 15,751 | 50,875 ± 79,458 | 27,983 ± 52,140 |
| Respiratory Diseases/ Asthma/Bronchitis | 11,582 ± 17,554 | 18,400 ± 15,969 | 13,682 ± 17,333 |
| Weakness/Dizziness | 5014 ± 5169 | 12,306 ± 17,488 | 7639 ± 11,726 |
| Pneumonia | 7364 ± 8310 | 31,639 ± 99,655 | 13,850 ± 52,575 |
| Tuberculosis | 10,069 ± 9123 | 13,617 ± 14,003 | 11,589 ± 11,115 |
| Malaria | 4267 ± 2674 | 6200 ± 3811 | 4911 ± 3005 |
| Jaundice | 10,776 ± 10,213 | 16,040 ± 14,370 | 12,772 ± 11,993 |
| Female diseases | 12,146 ± 10,573 | 25,149 ± 19,268 | 20,454 ± 17,760 |
| Child delivery and pregnancy-related diseases | 12,632 ± 12,526 | 18,735 ± 19,043 | 16,906 ± 17,562 |
| Cancer | 40,488 ± 35,630 | 56,131 ± 57,878 | 47,983 ± 47,735 |
| Mental health | 23,467 ± 30,268 | 24,517 ± 17,707 | 23,692 ± 27,764 |
| Paralysis | 19,068 ± 15,778 | 42,328 ± 47,969 | 26,196 ± 31,101 |
| Scabies/Skin diseases | 11,689 ± 11,622 | 35,378 ± 29,571 | 19,304 ± 21,819 |
| Kidney Diseases | 23,326 ± 22,836 | 26,168 ± 24,188 | 24,810 ± 23,490 |
| Liver Diseases | 23,613 ± 21,736 | 36,472 ± 37,366 | 29,328 ± 30,143 |
| Ear/ ENT problems | 15,239 ± 26,091 | 29,450 ± 21,045 | 22,789 ± 24,247 |
| Eye problem | 10,393 ± 10,069 | 24,112 ± 34,730 | 19,891 ± 30,054 |
| Communicable | 8312 ± 10,738 | 15,221 ± 26,959 | 13,336 ± 22,266 |
| Non-communicable | 19,560 ± 29,962 | 28,467 ± 42,495 | 20,247 ± 34,303 |
Fig. 2Incidence of distress and catastrophic health expenditure at 10% of THCE and 25% of NFE on hospitalization in Bangladesh
Health care provider specific incidence of catastrophic health expenditure and distress financing due to out-of-pocket spending on hospitalization in Bangladesh
| Diseases/reasons for hospitalization | Catastrophic health expenditure due to hospitalization | Distress financing due to hospitalization | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Diarrhea/Dysentery | 9 (3.4) | 2 (3.0) | 11 (3.3) | 7 (2.6) | 4 (6.0) | 11 (3.3) | 120 (41.7) | 20 (31.7) | 140 (39.9) |
| Fever | 11 (8.1) | 8 (17.4) | 19 (10.4) | 15 (11.1) | 6 (12.8) | 21 (11.5) | 73 (51.4) | 25 (54.3) | 98 (52.1) |
| Pain | 24 (14.5) | 23 (29.5) | 47 (19.3) | 22 (13.5) | 16 (19.8) | 38 (15.6) | 81 (47.4) | 66 (67.3) | 147 (54.6) |
| Injury/Accident | 72 (29.2) | 52 (48.6) | 124 (35.0) | 57 (23.2) | 38 (35.2) | 95 (26.8) | 158 (60.8) | 71 (65.1) | 229 (62.1) |
| Blood pressure | 12 (16.0) | 7 (20.6) | 19 (17.43) | 13 (16.9) | 6 (18.8) | 19 (17.4) | 38 (48.7) | 18 (56.3) | 56 (50.9) |
| Heart disease | 24 (16.7) | 44 (53.3) | 68 (30.2) | 19 (13.4) | 29 (34.9) | 48 (21.3) | 90 (62.1) | 59 (72.0) | 149 (65.6) |
| Respiratory Diseases/ Asthma/Bronchitis | 25 (17.2) | 20 (30.8) | 45 (21.4) | 18 (12.6) | 18 (26.9) | 36 (17.1) | 87 (59.6) | 39 (60.0) | 126 (59.7) |
| Weakness/Dizziness | 6 (9.7) | 4 (11.4) | 10 (10.3) | 5 (8.2) | 4 (11.1) | 9 (9.3) | 40 (62.5) | 23 (63.9) | 63 (63.0) |
| Pneumonia | 6 (6.9) | 8 (23.5) | 14 (11.2) | 8 (8.9) | 5 (14.3) | 13 (10.4) | 49 (51.0) | 23 (65.7) | 72 (55.0) |
| Tuberculosis | 3 (37.5) | 1 (16.7) | 4 (28.6) | 3 (37.5) | 1 (16.7) | 4 (28.6) | 5 (62.5) | 4 (66.7) | 9 (64.3) |
| Malaria | - | - | - | - | - | - | 3 (50.0) | 2 (66.7) | 5 (55.6) |
| Jaundice | 4 (22.2) | 2 (18.2) | 6 (20.7) | 6 (33.3) | - | 6 (20.7) | 10 (55.6) | 4 (36.4) | 14 (48.3) |
| Female diseases | 13 (25.5) | 50 (54.4) | 63 (44.1) | 13 (24.5) | 41 (45.6) | 54 (37.8) | 29 (55.8) | 70 (76.1) | 99 (68.8) |
| Child delivery and pregnancy-related diseases | 27 (20.9) | 134 (35.5) | 171 (30.8) | 28 (15.6) | 99 (26.3) | 127 (22.9) | 106 (62.7) | 218 (55.2) | 324 (57.4) |
| Cancer | 11 (44.0) | 13 (56.5) | 24 (50.0) | 8 (32.0) | 10 (43.5) | 18 (37.5) | 19 (76.0) | 20 (87.0) | 39 (81.3) |
| Mental health | 8 (36.4) | 3 (50.0) | 11 (39.3) | 5 (22.7) | 2 (33.3) | 7 (25.0) | 19 (86.4) | 5 (83.3) | 24 (85.7) |
| Paralysis | 17 (39.5) | 10 (52.6) | 27 (43.6) | 14 (31.8) | 7 (38.9) | 21 (33.9) | 29 (67.4) | 14 (73.7) | 43 (69.4) |
| Scabies/Skin diseases | 4 (22.2) | 4 (44.4) | 8 (29.6) | 4 (22.2) | 2 (22.2) | 6 (22.2) | 11 (57.9) | 5 (55.6) | 16 (57.1) |
| Kidney Diseases | 21 (38.2) | 20 (34.5) | 41 (36.3) | 18 (33.3) | 17 (28.8) | 35 (31.0) | 36 (66.7) | 37 (62.7) | 73 (64.6) |
| Liver Diseases | 19 (54.3) | 12 (42.9) | 31 (49.2) | 18 (51.4) | 10 (35.7) | 28 (44.4) | 25 (71.4) | 19 (67.9) | 44 (69.8) |
| Ear/ ENT problems | 3 (20.0) | 6 (35.3) | 9 (28.1) | 2 (13.3) | 6 (35.3) | 8 (25.0) | 9 (60.0) | 13 (76.5) | 22 (68.8) |
| Eye problem | 7 (17.1) | 27 (30.7) | 34 (26.4) | 5 (12.5) | 21 (23.6) | 26 (20.2) | 25 (62.5) | 51 (56.7) | 76 (58.5) |
| Communicable | 108 (13.6) | 218 (33.6) | 326 (22.6) | 100 (12.6) | 168 (25.9) | 268 (18.6) | 435 (51.7) | 385 (56.7) | 820 (53.9) |
| Non-communicable | 230 (22.9) | 231 (37.6) | 461 (28.5) | 192 (19.1) | 178 (28.9) | 370 (22.9) | 627 (59.4) | 421 (65.3) | 1,048 (61.6) |
Numerator: number of households experienced CHE and distress financing, Denominator: number of households experienced at least one hospitalization for the specific diseases/reasons
Fig. 3Disease specific-destress financing and catastrophic health expenditure at 10% of THCE on hospitalization in Bangladesh
Fig. 4Concentration curves and indices for healthcare utilization from the public and private hospitals due to hospitalization
Fig. 5Concentration curves and indices for catastrophic spending and destress financing on hospitalization due to OOP healthcare spending
Determinants of catastrophic health expenditure and distress financing due to out-of-pocket health expenditure on hospitalization in Bangladesh
| Variables | Catastrophic healthcare spending | Model C (Distress financing) | |
|---|---|---|---|
| < | 1.00 | 1.00 | 1.00 |
| ≥ | 0.92 (0.83, 1.02) | 0.95 (0.84, 1.06) | 0.93 (0.84, 1.03) |
| | 1.00 | 1.00 | 1.00 |
| | 1.00 (0.91, 1.10) | 1.05 (0.94, 1.16) | 1.02 (0.94, 1.11) |
| | 1.03 (0.90, 1.18) | 1.18a (1.02, 1.36) | 1.10 (0.98, 1.24) |
| | 1.00 | 1.00 | 1.00 |
| | 0.99 (0.88, 1.10) | 0.95 (0.84, 1.06) | 0.96 (0.85, 1.07) |
| | 0.84 (0.68, 1.04) | 0.97 (0.78, 1.20) | 0.87 (0.73, 1.04) |
| | 1.00 | 1.00 | 1.00 |
| | 0.81b (0.73, 0.90) | 0.82b (0.73, 0.92) | 0.88b (0.80, 0.96) |
| | 0.69b (0.59, 0.81) | 0.56b (0.47, 0.67) | 0.82b (0.73, 0.93) |
| | 1.00 | 1.00 | 1.00 |
| | 1.17b (1.05, 1.31) | 1.11 (0.98, 1.25) | 1.40b (1.27, 1.54) |
| | 0.87 (0.77, 1.01) | 0.89 (0.79, 1.03) | 1.51b (1.37, 1.67) |
| | 1.00 | 1.00 | 1.00 |
| | 2.49b (2.14, 2.90) | 2.88b (2.47, 3.37) | 0.73b (0.64, 0.84) |
| | 1.00 | 1.00 | 1.00 |
| | 3.03b (2.78, 3.31) | 2.28b (2.08, 2.49) | 1.37b (1.27, 1.48) |
| | 1.00 | 1.00 | 1.00 |
| | 1.64b (1.49, 1.79) | 1.52b (1.38, 1.67) | 1.39b (1.28, 1.50) |
| | 1.00 | 1.00 | 1.00 |
| | 0.85 (0.69, 1.06) | 0.75a (0.60, 0.94) | 0.88 (0.71, 1.08) |
| | 0.67b (0.53, 0.85) | 0.62b (0.48, 0.78) | 1.00 (0.80, 1.25) |
| | 1.00 | 1.00 | 1.00 |
| | 0.38b (0.33, 0.44) | 0.48b (0.41, 0.55) | 1.35b (1.18, 1.53) |
| | 0.54b (0.47, 0.63) | 0.62b (0.53, 0.73) | 0.69b (0.61, 0.79) |
| | 0.53b (0.46, 0.62) | 0.67b (0.57, 0.79) | 1.36b (1.19, 1.56) |
| | 0.49b (0.39, 0.62) | 0.71b (0.56, 0.89) | 0.91 (0.74, 1.11) |
| | 0.51b (0.43, 0.60) | 0.55b (0.46, 0.65) | 0.78b (0.67, 0.90) |
| | 0.58b (0.49, 0.69) | 0.72b (0.60, 0.86) | 1.43b (1.21, 1.67) |
| | 0.48b (0.40, 0.58) | 0.69b (0.57, 0.84) | 1.08 (0.92, 1.27) |
| | 1.00 | 1.00 | 1.00 |
| | 0.86b (0.78, 0.94) | 0.75b (0.68, 0.84) | 0.74b (0.68, 0.80) |
| | 2.78b (2.39, 3.22) | 2.98b (2.53, 3.50) | 3.56b (3.12, 4.05) |
| | 2.49b (2.15, 2.88) | 2.60b (2.21, 3.05) | 2.11b (1.88, 2.38) |
| | 2.01b (1.75, 2.31) | 2.64b (2.27, 3.08) | 2.23b (2.00, 2.50) |
| | 1.92b (1.69, 2.20) | 1.94b (1.67, 2.25) | 1.80b (1.63, 2.00) |
| | 1.00 | 1.00 | 1.00 |
a 5% level of significance
b 1% level of significance